GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus
GRAIL Inc shares were down 3.3% at $84.95 in afternoon trading on Tuesday, after earlier touching $84.77.
GRAIL stock dives nearly 50% after UK Galleri trial misses key goal, raising FDA questions
GRAIL, Inc. shares tumbled 49.8% to $51.00 during Friday afternoon trading, hitting a session low of $45.51 earlier amid heavy volume.
TechStock² Updates
![Asia Stock Market Today 28/08/2026 [UPDATE: 00:51 SGT] [Salesforce Leads KASE Global Into Final Minutes After Asia’s Split Close]](https://ts2.tech/wp-content/uploads/2026/08/Asia-market-dashboard-2026-08-28-0051-480x384.jpg "Asia Stock Market Today 28/08/2026 [UPDATE: 00:51 SGT] [Salesforce Leads KASE Global Into Final Minutes After Asia’s Split Close]")
